To the best of our knowledge, this is the first report on monitoring of chemotherapy induced activation of pro-survival ERK1/2 and AKT arm in cancer cells derived from malignant ascites by BRET technology, which may offer unique application of these sensors in clinical sectors to foresee efficacy of chemotherapeutics. The gene discussed is AKT1; the disease is cancer.